Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

PCI Synthesis Appoints R&D VP



Published June 1, 2012
Related Searches: R&D Promotions & Moves Development
Alexander Tretyakov has been appointed vice president of R&D at PCI Synthesis, Inc. Mr. Tretyakov will provide technical leadership across the company, specifically in creating de novo synthetic schemes and approaches. He will work with customers to provide oversight and professional development opportunities for the R&D department.
 
Prior to joining the company, Mr. Tretyakov spent nine years at Cambridge Major Laboratories, where he served most recently as vice president of R&D. Previously he launched Omega Engineering, providing custom synthesis solutions to the pharmaceutical and fine chemical industries. Prior to that he held roles as plant chemist, pilot plan operations supervisor, scientist and chemical engineer at various chemical manufacturers.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On